Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Unknown 2Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Unresectable Solid Tumors 1Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Lung Cancer Patients 1High-Burden Metastatic Solid Tumors 1Disease 1Carcinoma, Hepatocellular 1

Interventions

lenvatinib 16Bevacizumab 14sintilimab 10tislelizumab 9apatinib 9regorafenib 6camrelizumab 6donafenib 5atezolizumab 5Immune Checkpoint Inhibitors 4Hepatectomy 4cabozantinib 3Radiosurgery 3Capecitabine 3spartalizumab 2pembrolizumab 2durvalumab 2anlotinib 2Surgical Procedures, Operative 2Specimen Handling 2Oxaliplatin 2Observation 2Magnetic Resonance Spectroscopy 2Injections 2Immunotherapy 2Folfox protocol 2Fecal Microbiota Transplantation 2Electroporation 2Blood Specimen Collection 2ursodoxicoltaurine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Hepatocellular × Cryosurgery × Clear all
NCT06530784 2024-07-31

Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting
36 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡